Jefferies lowered the firm’s price target on Keurig Dr Pepper (KDP) to $39 from $41 and keeps a Buy rating on the shares after “a largely successful” investor day getting investors to move past “errors of the original JDEP deal.” The nature of the deal is tricky, as the new $7B strategic investment swaps out traditional debt with a payout structure that involves a joint venture and preferred equity, but the firm thinks the strategic rationale and accretion targets remain “sensible” and unchanged, the analyst tells investors.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper’s Risky Venture: Strategic Investment in Pod Manufacturing JV Threatens Flexibility and Shareholder Value
- Keurig Dr Pepper’s Earnings Call: Strong Q3 and Strategic Plans
- Keurig Dr Pepper price target raised to $30 from $26 at Barclays
- Balanced Hold Rating on Keurig Dr Pepper Amid Strategic Moves and Investment Complexities
- Keurig Dr Pepper price target raised to $35 from $33 at Wells Fargo
